Business Context and Reporting Period
Company: Future Vision II Acquisition Corp. (FVN)
Reporting Period: Quarter ended March 31, 2025
Business Type: Cayman Islands exempted company (SPAC) formed on January 30, 2024, to effect a business combination. The Company consummated its Initial Public Offering (IPO) on September 13, 2024, raising $57.5 million (including over-allotment). As of the reporting date, the Company has not commenced operations and is actively pursuing a merger with VIWO Technology Inc., pursuant to a Merger Agreement signed on November 28, 2024.
Key Financial Metrics
| Metric | Value (USD) |
|---|---|
| Total Assets | $60,427,482 |
| Cash and Cash Equivalents | $1,142,445 |
| Marketable Securities (Trust Account) | $59,218,058 |
| Total Liabilities | $141,333 |
| Ordinary Shares Subject to Redemption | $53,238,240 |
| Shareholders' Equity | $7,047,909 |
| Net Income (Q1 2025) | $454,300 |
| Operating Expenses (Q1 2025) | $166,900 |
| Trust Account Income (Q1 2025) | $612,361 |
Material Changes vs. Prior Period
- Profitability: The Company reported a net income of $454,300 for the three months ended March 31, 2025, compared to a net loss of $2,091 for the period from inception (Jan 30, 2024) through March 31, 2024. The current period income is driven primarily by $612,361 in income earned on marketable securities held in the Trust Account.
- Trust Account Growth: Marketable securities in the Trust Account increased from $58,605,697 at December 31, 2024, to $59,218,058 at March 31, 2025, reflecting interest accumulation.
- Operating Expenses: Formation and operating costs rose to $136,900 in Q1 2025, compared to $2,091 in the prior period, alongside a new $30,000 administrative fee payable to the Sponsor.
- Equity Accretion: The Company recorded an accretion of ordinary shares subject to redemption value of $1,100,598, reducing Additional Paid-in Capital.
Outlook, Risks, and Management Commentary
- Business Combination Status: The Company has entered into a Merger Agreement with VIWO Technology Inc. The transaction requires shareholder approval and is subject to customary closing conditions. VIWO shareholders will receive approximately 9.95 million Future Vision ordinary shares upon consummation.
- Liquidity and Going Concern: Management has identified substantial doubt about the Company's ability to continue as a going concern. This is due to the mandatory liquidation requirement if a business combination is not completed by March 13, 2026 (or up to September 13, 2026 with extensions). Liquidity is currently supported by $1.14 million in operating cash and potential working capital loans from the Sponsor.
- Deferred Obligations: The Company owes a deferred underwriting commission of $575,000 in cash and 28,750 representative shares, payable upon the consummation of a business combination.
- Extension Rights: The Company may extend the time to consummate a business combination by up to six months through monthly extensions, subject to shareholder approval and payment of extension fees.
Investor Verification Checklist
- Merger Agreement Terms: Verify the specific valuation and consideration structure for the proposed merger with VIWO Technology Inc.
- Redemption Risk: Assess the likelihood of public shareholders redeeming their shares, which could impact the cash available for the transaction.
- Extension Fees: Confirm the cost and shareholder approval requirements for extending the combination period beyond the initial 18-month deadline.
- Working Capital Loans: Monitor the status of any working capital loans from the Sponsor or affiliates required to fund operations prior to the merger.
- Trust Account Yield: Review the interest rate environment and its impact on the Trust Account balance available for redemption or merger funding.